Sphenopalatine Ganglion Stimulation Upregulates Transport of Temozolomide across the Blood-Brain Barrier
Sphenopalatine ganglion (SPG) stimulation has been shown to reversibly alter blood-brain barrier (BBB) permeability. It is widely used for the treatment of cluster headaches in Europe and is well tolerated in humans. The therapeutic potential for SPG stimulation in other central nervous system (CNS)...
Main Authors: | Thana N. Theofanis, Ankit K. Rochani, Richard F. Schmidt, Michael J. Lang, Geoffrey P. Stricsek, Robert H. Rosenwasser, Ashwini D. Sharan, Gagan Kaushal, Lorraine Iacovitti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Scientia Pharmaceutica |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-0532/88/3/40 |
Similar Items
-
Sphenopalatine ganglion deficit syndrome: An unusual complication after septoplasty
by: Vincenzo Abbate, et al.
Published: (2020-12-01) -
Conventional radiofrequency ablation of sphenopalatine ganglion for the treatment of cluster headache
by: Sudhindra Dharmavaram, et al.
Published: (2016-01-01) -
Comparison of Temperature and Pain Changes between the Drip and Topical Methods of Administering the Transnasal Sphenopalatine Ganglion Block
by: Na Eun Kim, et al.
Published: (2022-05-01) -
Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study
by: Joan Crespi, et al.
Published: (2018-02-01) -
Sphenopalatine ganglion block for refractory COVID-19 headache: a descriptive case series
by: Felipe Chiodini Machado, et al.
Published: (2021-11-01)